Vor Biopharma VOR Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's operating income?
- Vor Biopharma (VOR) reported operating income of -$35.16M in Q1 2026.
- How has Vor Biopharma's operating income changed year-over-year?
- Vor Biopharma's operating income decreased by 5.6% year-over-year, from -$33.29M to -$35.16M.
- What is the long-term trend for Vor Biopharma's operating income?
- Over 4 years (2021 to 2025), Vor Biopharma's operating income has grown at a 52.3% compound annual growth rate (CAGR), from -$69.02M to -$371.64M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.